RKDA - Arcadia Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
5.76
+0.08 (+1.41%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close5.68
Open5.71
Bid6.16 x 800
Ask6.21 x 900
Day's Range5.60 - 5.92
52 Week Range1.82 - 10.40
Volume655,389
Avg. Volume3,140,769
Market Cap42.033M
Beta (3Y Monthly)-4.01
PE Ratio (TTM)N/A
EPS (TTM)-0.94
Earnings DateAug 14, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est15.00
Trade prices are not sourced from all markets
  • Davis ag-tech company raises $9.2 million to pursue growth opportunities
    American City Business Journals

    Davis ag-tech company raises $9.2 million to pursue growth opportunities

    Davis-based crop technology company Arcadia Biosciences Inc. said it raised $9.2 million from a direct offering of its stock to institutional and accredited investors.

  • Arcadia Biosciences Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market
    PR Newswire

    Arcadia Biosciences Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market

    DAVIS, Calif., Sept. 10, 2019 /PRNewswire/ -- Arcadia Biosciences, Inc. (RKDA), a food ingredient company and proven leader in agricultural innovation, improving the quality and nutritional content of crops, today announced the closing of its previously announced registered direct offering of 1,318,828 shares of its common stock. The offering was priced at-the-market at a purchase price per share of $7.52, for gross proceeds of approximately $9.92 million. Additionally, in a concurrent private placement, Arcadia issued unregistered warrants to purchase up to 659,414 shares of common stock, representing 50 percent of the shares of common stock purchased in the registered direct offering.

  • Benzinga

    The Week In Cannabis: The Vape Craze, Raises Hit $10B, Aurora Cashes In On TGOD, Seth Rogen's Charity Goes Green

    On Thursday, the New York State Department of Health came out with a theory around vitamin E acetate being the culprit. Meanwhile, Washington, D.C. enacted a law that provides protections to government employees who consume medical marijuana. While many were investing in the cannabis space, Aurora Cannabis Inc. (NYSE: ACB) has started cashing out on some of its investments.

  • Benzinga

    A Subsidiary Of Arcadia Bio Received A New Hemp License In California

    Arcadia Specialty Genomics, a hemp-focused operating unit of crop innovation company Arcadia Biosciences Inc (NASDAQ: RKDA ), announced this week plans for a new sun-grown hemp cultivation and agronomic ...

  • Arcadia Biosciences Announces $10 Million Registered Direct Offering Priced At-the-Market
    PR Newswire

    Arcadia Biosciences Announces $10 Million Registered Direct Offering Priced At-the-Market

    DAVIS, Calif., Sept. 6, 2019 /PRNewswire/ -- Arcadia Biosciences, Inc. (RKDA), a food ingredient company and proven leader in agricultural innovation, improving the quality and nutritional content of crops, today announced that it has entered into definitive agreements with several institutional and accredited investors for the purchase of 1,318,828 shares of its common stock, at a purchase price per share of $7.5825, in a registered direct offering priced at-the-market. Additionally, Arcadia has agreed to issue to the investors unregistered warrants to purchase up to 659,414 shares of common stock. The warrants to purchase up to 659,414 shares of common stock have an exercise price of $7.52 per share, will be immediately exercisable, and will expire five and one-half years from the issue date.

  • Arcadia Biosciences to Present at 21st Annual Global Investment Conference September 8-10, 2019
    PR Newswire

    Arcadia Biosciences to Present at 21st Annual Global Investment Conference September 8-10, 2019

    DAVIS, Calif. , Sept. 4, 2019 /PRNewswire/ --  Arcadia Biosciences, Inc. (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, ...

  • Arcadia Biosciences, Inc. (NASDAQ:RKDA) Insiders Increased Their Holdings
    Simply Wall St.

    Arcadia Biosciences, Inc. (NASDAQ:RKDA) Insiders Increased Their Holdings

    It is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...

  • GuruFocus.com

    Arcadia Biosciences Inc (RKDA) CFO Matthew T Plavan Bought $69,840 of Shares

    CFO of Arcadia Biosciences Inc (30-Year Financial, Insider Trades) Matthew T Plavan (insider trades) bought 8,000 shares of RKDA on 08/28/2019 at an average price of $8.73 a share. Continue reading...

  • Benzinga

    A Look At Benzinga Pro's Most-Searched Tickers For August 27, 2019

    This most-searched list is a feature included in Benzinga Pro's Newsfeed tool. It highlights stocks frequently searched by Benzinga Pro users on the platform. Taronis Technologies (NASDAQ: TRNX ) shares ...

  • Arcadia names new CEO, forecasts big revenue gains; stock soars
    American City Business Journals

    Arcadia names new CEO, forecasts big revenue gains; stock soars

    Shares of Davis-based Arcadia Biosciences Inc. rose more than 52% on Monday on a large revenue increase forecast by newly named CEO Matthew Plavan.

  • MarketWatch

    Arcadia stock rockets 35% after company issues bullish guidance for 2020 and 2021

    Shares of agricultural biotech company Arcadia Biosciences Inc. shot up 35% on Monday after the company said it expects total revenues in 2020 and 2021 to exceed $10 million and $30 million, respectively. The company said it expects to begin generating net cash from operations in 2021. Arcadia also announced that Chief Executive Raj Ketkar would retire in September and that the company's board had elected Chief Financial Officer Matthew Plavan as the company's new CEO. Shares of Arcadia have rocketed 174% in the year to date, while the S&P 500 has gained 14.7%.

  • Benzinga

    Arcadia Biosciences Rallies After Announcing Financial Guidance, Partnerships To Market High-Fiber Wheat

    Agricultural biotechnology company Arcadia Biosciences, Inc. (NASDAQ: RKDA) announced Monday that it has signed a binding term sheet agreement with Arista Cereal Technologies and Bay State Milling Company for the commercialization of its high-fiber wheat. Bay State Milling will become the exclusive commercial partner for the company’s high-fiber wheat in North America under Bay State Milling’s HealthSense brand portfolio. Arista, on the other hand, will obtain exclusive rights under Arcadia’s intellectual property in Australia, New Zealand, Japan, South Korea and Europe.

  • Arcadia Biosciences Announces Management Succession; Provides Financial Guidance
    PR Newswire

    Arcadia Biosciences Announces Management Succession; Provides Financial Guidance

    DAVIS, Calif., Aug. 26, 2019 /PRNewswire/ -- Arcadia Biosciences, Inc. (RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, announced today that Raj Ketkar, president and CEO, will retire effective September 1, 2019. In line with its succession plan, the board has appointed Matthew Plavan to chief executive officer and member of the board of directors. Plavan is succeeded by Pam Haley as Arcadia's new chief financial officer.

  • Arcadia Biosciences Enters Global Collaboration with Arista Cereal Technologies and Bay State Milling Company for Commercialization of High Fiber Wheat
    PR Newswire

    Arcadia Biosciences Enters Global Collaboration with Arista Cereal Technologies and Bay State Milling Company for Commercialization of High Fiber Wheat

    DAVIS, Calif., Aug. 26, 2019 /PRNewswire/ -- Arcadia Biosciences, Inc. (RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today announced a binding term sheet agreement with Arista Cereal Technologies and Bay State Milling Company for commercialization of its high fiber resistant starch wheat in key wheat markets, including North America, Europe and parts of Asia.

  • Thomson Reuters StreetEvents

    Edited Transcript of RKDA earnings conference call or presentation 14-Aug-19 8:30pm GMT

    Q2 2019 Arcadia Biosciences Inc Earnings Call

  • Benzinga

    Former MLB All-Star Shane Victorino Talks Plans To Give Back To Hawaii Through New Cannabis Venture

    A few notable names include former Heisman winner Ricky Williams, pro golfer Bubba Watson and NBA great Gary Payton. Former two-time World Series champion Shane Victorino is one of the latest to get involved. Victorino's Hawaii-based venture, Legacy Ventures Hawaii, recently partnered with Arcadia Biosciences (NASDAQ: RKDA) to launch a joint cultivation and extraction venture, Archipelago Ventures.

  • CNW Group

    Vapen MJ Reports 43% Revenue Increase, 23% Increase in Net Income, for Second Quarter of 2019

    Vapen MJ Reports 43% Revenue Increase, 23% Increase in Net Income, for Second Quarter of 2019

  • Benzinga

    Another Case For Consistent Trading

    Warrior Trading is a content partner of Benzinga. This post did not go through the Benzinga Newsdesk. Well, it took a half a month of struggles, but this Thursday marks the first time in August that I’ve ...

  • Benzinga

    A Look At Benzinga Pro's Most-Searched Tickers For August 15, 2019

    This most-searched list is a feature included in Benzinga Pro's Newsfeed tool. It highlights stocks frequently searched by Benzinga Pro users on the platform. Pivotal Software (NYSE: PVTL ) shares were ...

  • Arcadia Biosciences Announces Second-Quarter and First-Half 2019 Financial Results and Business Highlights
    PR Newswire

    Arcadia Biosciences Announces Second-Quarter and First-Half 2019 Financial Results and Business Highlights

    Company launches Archipelago™ Ventures, a strategic joint venture for superior hemp production and extraction in Hawaii DAVIS, Calif. , Aug. 14, 2019 /PRNewswire/ -- Arcadia Biosciences, Inc.  (Nasdaq: ...

  • MarketWatch

    Arcadia Biosciences' stock up on heavy volume again, but pulls way back from earlier peak

    Shares of Arcadia Biosciences Inc. rose in active trading again on Tuesday, but pulled back sharply from an earlier peak, as the rocket ride of the past two sessions appears ready for a pause. The stock's gains have come after the food ingredients and nutritional oils company's joint venture with Biocerese Crop Solutions Corp. , Verdeca, said last week that its HB4 drought-tolerant soybeans received approval from the U.S. Department of Agriculture. The stock was up 2.2% on volume of of 1.2 million shares ahead of Tuesday's open, but had been up as much as 25.5% earlier in the premarket. The stock had run up 244% over the past two sessions, including a 124.4% rally on volume of 56.7 million shares on Friday and a 53.7% surge on volume of 38.8 million shares on Monday. The stock has now more than doubled year to date through Monday (up 119%), while the S&P 500 has gained 15.0%.

  • MarketWatch

    Arcadia Biosciences rockets on heavy volume for a 2nd straight day

    Shares of Arcadia Biosciences Inc. rocketed higher again Monday, running up 53% on heavy volume after jetting 124% higher the previous session, to pace the Nasdaq exchanges gainers. Trading volume was 25.4 million shares, compared with the full-day average of about 2 million shares, and after turning over 56.7 million shares on Friday. The stock more than doubled on Friday after Verdeca, a joint venture between Arcadia and Bioceres Crop Solutions Corp. said its HB4 drought-tolerant soybeans received approval from the U.S. Department of Agriculture. Arcadia's stock has now gained 15.6% over the past 12 months, while the iShares Nasdaq Biotechnology ETF has lost 10.2% and the S&P 500 has edged up 2.2%. Arcadia's stock was back up toward levels last seen during the February-March rally, which was on the back of the company's announcement of a cannabis-focused business unit.

  • Davis biotech company shares soar following USDA approval
    American City Business Journals

    Davis biotech company shares soar following USDA approval

    Shares in Davis-based Arcadia Biosciences Inc. shot up 124% Friday on news of a USDA approval for drought-tolerant soybeans the company has developed in a joint partnership with Bioceres Crop Solutions Corp.

  • MarketWatch

    Arcadia Biosciences' stock rockets on heavy volume after USDA approval of drought-tolerant soybeans

    Shares of Arcadia Biosciences Inc. rocketed 97.5% on very heavy volume Friday, after Verdeca, a joint venture between Arcadia and Bioceres Crop Solutions Corp. , said it received approval from the U.S. Department of Agriculture to commercialize its HB4 drought-tolerant soybeans. Trading volume in Arcadia's stock was 28.5 million shares, compared with the full-day average of about 127,000 shares. The rally comes after the stock closed at a record low of $1.92 on Monday Aug. 5. Bioceres's stock rose 6% in morning trading. "HB4 is a novel soybean trait that enhances the traditional herbicide tolerance package to provide yield stability across diverse environments," said Verdeca General Manager Martin Mariani Ventura. "Approval of this technology in the United States is a significant step for the successful commercialization of HB4 technology in the global soybean market." Arcadia's stock has still lost 22.7% over the past three months, while Bioceres shares have run 54.5% and the S&P 500 has gained 1.3%.

  • Verdeca Receives USDA Approval of HB4® Drought Tolerant Soybeans
    PR Newswire

    Verdeca Receives USDA Approval of HB4® Drought Tolerant Soybeans

    -- Novel trait stack expected to help growers facing climate and production challenges -- -- HB4 trait now has regulatory approval in more than 80 percent of the global soybean market -- DAVIS, Calif. ...